FDA: Transgender Puberty Blocking Drugs linked to Deaths
Oct 8, 2019 14:40:23 GMT
Post by Admin on Oct 8, 2019 14:40:23 GMT
Transgender Puberty Blocking Drug Linked To Thousands Of Deaths, FDA Data Reveals
DailyWire.com | Sept. 26, 2019
More than 6,300 adults have died from reactions to a drug that is used as a puberty blocker in gender-confused children, Food & Drug Administration data shows.
“Between 2012 and June 30 of this year, the FDA documented over 40,764 adverse reactions suffered by patients who took Leuprolide Acetate (Lupron), which is used as a hormone blocker. More than 25,500 reactions logged from 2014-2019 were considered ‘serious,’ including 6,370 deaths,” The Christian Post reported on Thursday.
“Lupron is being prescribed off-label for use in children who have been diagnosed with gender dysphoria despite the lack of formal FDA approval for that purpose,” the outlet explained. “The drug is clinically approved for treatment of precocious puberty, a condition where children start their pubertal processes at an abnormally early age and the blocker is administered for a short time until the proper age.”